Contributions of COPD, asthma, and ten comorbid conditions to health care utilization and patient-centered outcomes among US adults with obstructive airway disease

International Journal of COPD

Volumn 12, Issue , 2017, Pages 2515-2522

  Murphy, Terrence E ^a   McAvay, Gail J ^a   Allore, Heather G ^a   Stamm, Jason A ^b   Simonelli, Paul F ^b  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b GEISINGER MEDICAL CENTER   (United States)

Author keywords

AAF; Average attributable fraction; Chronic obstructive pulmonary disease; COPD; Health care utilization; Patient centered outcomes

Indexed keywords

ADULT; ANGINA PECTORIS; ARTHRITIS; ARTICLE; ASTHMA; CEREBROVASCULAR ACCIDENT; CHRONIC OBSTRUCTIVE LUNG DISEASE; COGNITIVE DEFECT; COMORBIDITY; DIABETES MELLITUS; EMERGENCY WARD; FEMALE; HEALTH CARE UTILIZATION; HEART INFARCTION; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASM; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; SELF REPORT; TRANSIENT ISCHEMIC ATTACK; UNITED STATES; AGED; AMBULATORY CARE; ECONOMICS; HEALTH CARE COST; HEALTH CARE PLANNING; HEALTH CARE SURVEY; HEALTH STATUS; HOSPITAL EMERGENCY SERVICE; HOSPITALIZATION; MIDDLE AGED; PATIENT CARE; PROSPECTIVE STUDY; RISK FACTOR; TIME FACTOR; TREATMENT OUTCOME; UTILIZATION;

ADULT; AGED; AMBULATORY CARE; ASTHMA; COMORBIDITY; EMERGENCY SERVICE, HOSPITAL; FEMALE; HEALTH CARE COSTS; HEALTH CARE SURVEYS; HEALTH EXPENDITURES; HEALTH RESOURCES; HEALTH STATUS; HOSPITALIZATION; HUMANS; MALE; MIDDLE AGED; PATIENT-CENTERED CARE; PROSPECTIVE STUDIES; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME; UNITED STATES;

EID: 85028586030     PISSN: 11769106     EISSN: 11782005     Source Type: Journal    
DOI: 10.2147/COPD.S139948     Document Type: Article

References (29)

1. Dhamane AD, Moretz C, Zhou Y, et al. COPD exacerbation frequency and its association with health care resource utilization and costs. Int J Chron Obstruct Pulmon Dis. 2015;10:2609–2618.
2. Anecchino C, Rossi E, Fanizza C, et al. Prevalence of chronic obstructive pulmonary disease and pattern of comorbidities in a general population. Int J Chron Obstruct Pulmon Dis. 2007;2(4):567–574.
3. Barnes PJ, Celli BR. Systemic manifestations and comorbidities of COPD. Eur Respir J. 2009;33(5):1165–1185.
4. Ford ES. Hospital discharges, readmissions, and ED visits for COPD or bronchiectasis among US adults: findings from the nationwide inpatient sample 2001–2012 and Nationwide Emergency Department Sample 2006–2011. Chest. 2015;147(4):989–998.
5. Gershon AS, Guan J, Victor JC, Goldstein R, To T. Quantifying health services use for chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2013;187(6):596–601.
6. Vaz Fragoso CA, Murphy TE, Agogo GO, Allore HG, McAvay GJ. Asthma-COPD overlap syndrome in the US: a prospective population-based analysis of patient-reported outcomes and health care utilization. Int J Chron Obstruct Pulmon Dis. 2017;12:517–527.
7. Singer JP, Yusen RD. Defining patient-reported outcomes in chronic obstructive pulmonary disease: the patient-centered experience. Med Clin North Am. 2012;96(4):767–787.
8. Dulohery MM, Schroeder DR, Benzo RP. Cognitive function and living situation in COPD: is there a relationship with self-management and quality of life? Int J Chron Obstruct Pulmon Dis. 2015;10:1883–1889.
9. Jones PW, Rennard S, Tabberer M, Riley JH, Vahdati-Bolouri M, Barnes NC. Interpreting patient-reported outcomes from clinical trials in COPD: a discussion. Int J Chron Obstruct Pulmon Dis. 2016;11:3069–3078.
10. Kwon HY, Kim E. Factors contributing to quality of life in COPD patients in South Korea. Int J Chron Obstruct Pulmon Dis. 2016;11:103–109.
11. Celli BR, Decramer M, Wedzicha JA, et al. An Official American Thoracic Society/European Respiratory Society Statement: research questions in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2015;191(7):e4–e27.
12. Tinetti ME, McAvay GJ, Murphy TE, Gross CP, Lin H, Allore HG. Contribution of individual diseases to death in older adults with multiple diseases. J Am Geriatr Soc. 2012;60(8):1448–1456.
13. Lin H, Allore HG, McAvay G, et al. A method for partitioning the attributable fraction of multiple time-dependent coexisting risk factors for an adverse health outcome. Am J Public Health. 2013;103(1):177–182.
14. Juthani-Mehta M, De Rekeneire N, Allore H, et al. Modifiable risk factors for pneumonia requiring hospitalization of community-dwelling older adults: the Health, Aging, and Body Composition Study. J Am Geriatr Soc. 2013;61(7):1111–1118.
15. Allore HG, Zhan Y, Cohen AB, Tinetti ME, Trentalange M, McAvay G. Methodology to estimate the longitudinal average attributable fraction of guideline-recommended medications for death in older adults with multiple chronic conditions. J Gerontol A Biol Sci Med Sci. 2016;71(8):1113–1116.
16. US Department of Health & Human Services. Medical Expenditure Panel Survey; survey background [revised August 2009]. Available at: https://meps.ahrq.gov/mepsweb/about_meps/survey_back.jsp. Accessed December 8, 2016.
17. Levin ML. The occurrence of lung cancer in man. Acta Unio Internationalis Contra Cancrum. 1953;9:531–541.
18. Rowe AK, Powell KE, Flanders WD. Why population attributable fractions can sum to more than one. Am J Prev Med. 2004;26(3):243–248.
19. Eide GE, Gefeller O. Sequential and average attributable fractions as aids in the selection of preventive strategies. J Clin Epidemiol. 1995;48(5):645–655.
20. Ramsch C, Pfahlberg AB, Gefeller O. Point and interval estimation of partial attributable risks from case-control data using the R-package ‘pARccs’. Computer Methods Programs Biomed. 2009;94:88–95.
21. Murphy TE, McAvay G, Carriero NJ, et al. Deaths observed in Medicare beneficiaries: average attributable fraction and its longitudinal extension for many diseases. Stat Med. 2012;31(27):3313–3319.
22. Holguin F, Folch E, Redd SC, Mannino DM. Comorbidity and mortality in COPD-related hospitalizations in the United States, 1979 to 2001. Chest. 2005;128(4):2005–2011.
23. Yeatts KB, Lippmann SJ, Waller AE, et al. Population-based burden of COPD-related visits in the ED: return ED visits, hospital admissions, and comorbidity risks. Chest. 2013;144(3):784–793.
24. Mannino DM, Thorn D, Swensen A, Holguin F. Prevalence and outcomes of diabetes, hypertension and cardiovascular disease in COPD. Eur Respir J. 2008;32(4):962–969.
25. van Manen JG, Bindels PJ, Dekker EW, et al. Added value of co-morbidity in predicting health-related quality of life in COPD patients. Respir Med. 2001;95(6):496–504.
26. van Manen JG, Bindels PJ, Dekker FW, et al. The influence of COPD on health-related quality of life independent of the influence of comorbidity. J Clin Epidemiol. 2003;56(12):1177–1184.
27. Wijnhoven HA, Kriegsman DM, Hesselink AE, de Haan M, Schellevis FG. The influence of co-morbidity on health-related quality of life in asthma and COPD patients. Respir Med. 2003;97(5):468–475.
28. Park SK, Richardson CR, Holleman RG, Larson JL. Frailty in people with COPD, using the National Health and Nutrition Evaluation Survey dataset (2003–2006). Heart Lung. 2013;42(3):163–170.
29. Iyer AS, Bhatt SP, Garner JJ, et al. Depression is associated with readmission for acute exacerbation of chronic obstructive pulmonary disease. Ann Am Thorac Soc. 2016;13(2):197–203.